In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Amoun Pharmaceutical Co. SAE

Division of Bausch Health Companies Inc.
www.amoun.com

Latest From Amoun Pharmaceutical Co. SAE

Biopharma Quarterly Dealmaking Statistics, Q3 2015

Biopharma financing totaled $9.7 billion, almost half from follow-on public offerings; there was big consolidation in the generics and health services industries. AstraZeneca signed a dozen partnerships, many of which focused on oncology.

BioPharmaceutical Deals
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Amoun Pharmaceutical Industries Co.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Middle East
      • Egypt
  • Parent & Subsidiaries
  • Bausch Health Companies Inc.
  • Senior Management
  • Mohamed Roushdy, Chmn. & CEO
    Wahid Helmy, VP, CFO
    Helmy Hamada, Sr. Dir. Bus. Dev.
    Amin Wadie, VP, Commercial Ops.
  • Contact Info
  • Amoun Pharmaceutical Co. SAE
    Phone: 24614 0100
    1st industrial zone -block
    Cairo,
    Egypt
UsernamePublicRestriction

Register